We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Baroreflex activation therapy plus optimal medical ...
BOSTON, MA—Baroreflex activation therapy (BAT) delivered by the Barostim implant (CVRx) is associated with a range of benefits in patients who have advanced heart failure with reduced ejection ...
SAN DIEGO, CA — In a small trial of patients with heart failure and reduced ejection fraction (HF-REF), those who were implanted with the Barostim neo (CVRx) device, which stimulates baroreceptors in ...
TUCSON, Ariz. (KVOA) - Carondelet St. Mary's Hospital has successfully completed its first implantation of the Barostim™ Baroreflex Activation Therapy device, marking a significant advancement in the ...
Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation Receive the the latest news, research, and presentations from ...
MINNEAPOLIS, March 02, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved revised instructions for use for a neuromodulation device for HF. The instructions now include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results